CXCL12/CXCR4 activation significantly enhances the proliferation and invasion of cancer cells.[86] Furthermore, cancer cells release various factors including TGF-β, IL-6, VEGF, and PTHrP, which stimulate osteoblasts to increase RANKL expression. Here, PTHLH is linked to cancer.